Use of nutrotquipment for coping with the side effects of statins

Veröffentlicht:

Aktualisiert:

Von:

Use of nutrotquades to cope with the side effects of statins by Prof. Gene Bruno, MS, MHS, RH (AHG) Huntington College of Health Sciences in Allopathic Medicine are Statin medication (HMG-COA-Reductase-inhibitors) for the treatment of hypercholesterolaemia. Certainly there are a considerable number of research results that show that statins are effective for this purpose, although such therapy is not without the risk of side effects. To a certain extent, the risk of side effects can be dealt with by using specific nutrotional agents. Statins, myopathy and Coenzyme Q10 Muscle Skeleton Symptoms (e.g. myopathy) are perhaps the most commonly reported side effects related to statin therapy.1 ...
(Symbolbild/natur.wiki)

Use of nutrotquipment to cope with the side effects of statins

by Prof. Gene Bruno, MS, MHS, RH (AHG) Huntington College of Health Sciences

In allopathic medicine, Statin drugs (HMG-COA reductase inhibitors) are standard therapy for the treatment of hypercholesterolemia. Certainly there are a considerable number of research results that show that statins are effective for this purpose, although such therapy is not without the risk of side effects. To a certain extent, the risk of side effects can be handled by using specific nutrotquipment.

statine, myopathy and coenzyme Q10
Muscle skeleton symptoms (e.g. myopathy) are perhaps the most commonly reported side effects in connection with statin therapy.1 Myopathy can partially related to the inhibition of the endogenous synthesis of coenzyme Q10 (COQ10) by statins, an essential cofactor for mitochondrial energy production. Supplementation with COQ10 that can reduce muscular side effects caused by statins. In some studies, patients with statin-induced myopathy, which had 100 mg/coq10, had a significantly reduced pain intensity compared to the starting value and compared to a control group treatment of cancer, the supplementation with Coenzyme Q10 reduced the dose-limiting statin toxicity in myopathy, however, that other examinations should be taken into account have that COQ10 significantly improves the pain related to statin-induced myopathy compared to placebo. 6-7

statine and beta-sitosterol absorption
Beta-Sitosterol and other plant sterins have proven to be effective to reduce the absorption of cholesterol from food and thus the cholesterol level in the serum.8-9 In fact, research is so convincing that the FDA (US Food and Drug Administration) has actually approved a health-related statement for plants, which indicates that its consumption (in combination with an appropriate diet) Heart diseases can reduce cholesterol levels. In addition, there are several studies that show the effectiveness of beta-sitosterol to reduce the symptoms of the lower urinary tract (luts) in men (especially in cases of bph ).10-16

Since a systematic review and meta-analysis from 2016, showed that men with luts have an increased risk of serious undesirable cardiac events (p = 0.01), 17 is likely that men who use beta-sitosterol supplements for luts may also help take medication against luts to reduce serum cholesterol. This can be problematic, since the pravastatin statin medication (another cholesterol-lowering drug) can also reduce the blood mirror of Beta-Sitosterol by about 60 percent after four weeks.18 Theoretically, this could occur with other HMG-COA reductase inhibitors, although this is the case with Simvastatin. Ezetimib reduces the blood level of beta-sitosterin by about 40 percent.20-21 This is the case in men that beta-sitosterol use for luts, it is worth increasing the dose by 40 to 60 percent if they also take statins or ezetimib.

refer to
1 Backes JM, Ruisinger JF, Gibson CA, Moriarty PM. Statin-associated muscle symptoms-handling of highly intolerant. j clin lipidol . 2017 Jan-Feb; 11 (1): 24-33. 2 Caso G., Kelly P., McNurlan Ma., Lawson We. Effect of Coenzyme Q10 on myopathic symptoms in patients treated with statins. am j cardiol . May 15, 2007; 99 (10): 1409-12. 3 Kelly P., Vasu S. Getato M. McNurlan M. Lawson We. Coenzyme Q10 improves myopathic pain in patients treated with statins (abstr). j am Coll Cardiol 2005; 45: 3a. 4 Thibault A., Samid D., Tompkins AC, et al. Phase I study with Lovastatin, an inhibitor of the Mevalonate signal path, for cancer patients. Clinic Cancer Res 1996; 2: 483-91. 5 Kim WS, Kim mm, Choi HJ, et al. Phase II study with high-dose Lovastatin in patients with advanced adenocarcinoma of the stomach. Invest in new medication 2001; 19: 81-3. 6 L. Marcoff, P. D. Thompson. The role of Coenzyme Q10 in statin-associated myopathy: a systematic review. j am Coll Cardiol 2007; 49: 2231-7. 7 Young JM, Florkowski CM Molyneux SL MCEWAN RG Frmpton cm George PM. Coenzyme Q10 does not improve the tolerance of Simvastatin in patients with dyslipidemia and prior statin-induced myalgia. Verkehr 2007; 114: II41. 8 Racette SB, Lin X, Lefevre M, Spearie CA, MOST MM, MA L, Ostlund Re Jr. Dose Effects of Phytosterols from Food on Cholesterol Change: A controlled feeding study. Bin j clin nutr. 2010 Jan; 91 (1): 32-8. 9 Hendriks Hf, West Council yes, van Vliet T, Meijer Gw. Brot spreads, enriched with three different kept on vegetable oil states and the degree of cholesterol reduction in normocholesterineemic and slightly hypercholesterolemic people. EUR J Clin Nutr . 1999 Apr; 53 (4): 319-27. 10 Klippel KF, Hiltl DM, Schipp B. A multicenter, placebo-controlled, double-blind clinical study with beta-sitosterol (phytosterol) for the treatment of benign prostate hyperplasia. German BPH-Phyto study group. br. J. Urol 1997; 80 (3): 427-32. 11 Berges RR, diaper J, Trampisch HJ, Senge T. randomized, placebo-controlled, double-blind clinical study with beta-sitosterol in patients with benign prostate hyperplasia. Beta-sitosterol study group. lanzette 1995; 345 (8964): 1529-32. 12 Fischer A, Jurincic-Windlder CD, Klippel Kf. Conservative treatment of benign prostate hyperplasia with high-dose B-sitosterol (65 mg): Results of a placebo-controlled double-blind study. Uroscope 1993; 1: 12-20. 13 Y. Kobayashi, Y. Sugaya, A. Tokue. [Clinical Effects of Beta-Sitosterol (Phytosterol) on Benign Prostatic Hyperplasia: Preliminary Study] [Article in Japanese] Hinyokika Kiyo 1998; 44 (12): 865-8. 14 Berges RR, Kassen A, Senge T. Treatment of symptomatic benign prostate hyperplasia with beta-sitosterol: an 18-month follow-up. bju int 2000; 85 (7): 842-6. 15 Wilt TJ, MacDonald R, Ishani A. Beta-Sitosterol for the treatment of benign prostate hyperplasia: a systematic review. bju int 1999; 83 (9): 976-83. 16 Wilt T, Ishani A, MacDonald R, Stark G, Mulrow CD, Lau J. Beta-Sitosterine for Benigne prostate hyperplasia. Cochrane database of systematic reviews 1999; (3) Art. No.: CD001043; DOI: 10.1002/14651858. CD001043. 17 M. Gacci, G. Corona, A. Sebastianelli, S. Serni, C. de Nunzio, M. Maggi, L. Vignozzi, G. Novara, KT McVary, Sa Kaplan, S. Gravas, C. Chaple and Metaanalysis. EUROL. July 20, 2016. PII: S0302-2838 (16) 30405-5. 18 Hidaka H., Kojima H., Kawabata T., et al. Effects of an HMG-COA reductase inhibitor, pravastatin, and bile sequestry resin, cholestyramine, on the plasma plants with hypercholesterineemia. j Atheroscler thromb 1995; 2: 60-5. 19 NTanios Fy, Jones PJ, Fröhlich JJ. Effect of 3-hydroxy-3-methylglutaryl-coenzyme-a-reductase inhibitor on the sterol absorption in patients with hypercholesterolemia. metabolism 1999; 48: 68-73. 20 Salen G, by Bergmann K, Lutjohann d, et al. In patients with sitosterineemia, ezetimib effectively reduces the plant sterols in the plasma. Verkehr 2004; 109: 966-71. 21 Sudhop T., Lutjohann D., Kodal A., et al. Inhibition of intestinal cholesterol absorption by ezetimib in humans. Verkehr 2002; 106: 1943-8.

Professor Gene Bruno, MS, MHS, The Provost for Huntington College for Health Sciences, is a nutritionist, herbalist, writer and educator. For more than 37 years, he has been forming and trained in natural product dealers and medical specialists, has researched and formulated natural products for dozens of food supplements and has written articles and integrative health issues for trade and consumers publications and peer reviewed publications. It can be reached at gbruno@hchs.edu.

  • Allopathic medicine
  • beta-sitosterol absorption
  • Coenzyme Q10
  • Coq10
  • fda
  • hmg-coa reductase inhibitors
  • Symptoms of the lower urinary tract
  • luts
  • muscle skeleton symptoms
  • myopathy
  • patient
  • Plant sternine
  • Prof. Gene Bruno Blog
  • reduction of cholesterol in the serum
  • Statin medication
  • Statin therapy
  • treatment
  • US Food and Drug Administration

Read original items in English.